Geron Corporation (GERN) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Geron Corporation
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company's product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes…
Source: Yahoo Finance
Sector & Industry
Geron Corporation operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Geron Corporation at a Glance
| Company | Geron Corporation |
| Ticker | GERN |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $1.57 |
| Market cap | $1.01B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$0.11 |
| 52-week high | $2.01 |
| 52-week low | $1.04 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.60 |
| Return on equity (ROE) | -28.28% |
| Debt-to-equity | 55.87% |
| Average volume | 11.81M |
| Shares outstanding | 642.47M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 258 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Geron Corporation's current P/E ratio?
- Geron Corporation (GERN) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Geron Corporation's market capitalisation?
- Geron Corporation's market cap is $1.01B based on our latest snapshot. See how it ranks by market cap →
- What is GERN's 52-week range?
- Over the past 52 weeks, GERN has traded between $1.04 and $2.01. What does the 52-week range mean? →
- How volatile is Geron Corporation compared to the market?
- Geron Corporation has a beta of 0.60, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Geron Corporation pay a dividend?
- Geron Corporation does not currently pay a dividend according to our latest data.
- What exchange is GERN listed on?
- GERN is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Geron Corporation in?
- Geron Corporation is classified in the Healthcare sector. Compare with Healthcare peers →
Working out potential returns or position sizes? Our payout and odds calculators handle the maths.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →